Cargando…
Bioorthogonal Chemistry Approach for the Theranostics of GRPR-Expressing Cancers
Several gastrin-releasing peptide receptor (GRPR) antagonists with improved in vivo behavior have been recently developed and tested in the clinic. However, despite the generally mild side effects of peptide receptor radionuclide therapy (PRRT), toxicity has been observed due to high doses delivered...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785946/ https://www.ncbi.nlm.nih.gov/pubmed/36559063 http://dx.doi.org/10.3390/pharmaceutics14122569 |